Zobrazeno 1 - 10
of 101
pro vyhledávání: '"N. Premasathian"'
Autor:
N. Premasathian, Tanapon Pongnatcha, A. Vongwiwatana, Pera Panprom, Ratchawat Promraj, Nuttasith Larpparisuth
Publikováno v:
Therapeutic Drug Monitoring. 43:624-629
BACKGROUND High intrapatient variability in tacrolimus trough levels (Tac IPV) is associated with poor allograft outcomes. Tac IPV was previously calculated using trough levels 6-12 months after kidney transplantation (KT). Data on the accuracy of Ta
Autor:
Kawin Anusonadisai, Nattawut Wongpraparut, N. Premasathian, Archan Jaspttananon, Thunyarat Chaipruckmalakarn, Thongtum Tongdee, Rungtiwa Pongakasira, A. Vongwiwatana
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). According
Publikováno v:
Transplantation Proceedings. 51:3293-3296
Background Chronic active antibody-mediated rejection (CAMR) has unsatisfactory prognosis in spite of intensive standard antihumoral treatment. Efficacy of additional bortezomib in CAMR remains uncertain. Methods A retrospective chart review was cond
Publikováno v:
Transplantation Proceedings. 51:2620-2623
Background Converting to once-daily tacrolimus (Advagraf [Adv]) among renal transplant patients results in better drug adherence. Data regarding dosage and intrapatient variability changes after conversion among patients with CYP3A4/5 inhibitors (CYP
Autor:
N. Premasathian, Soontorn Pinpaiboon, Nuttasith Larpparisuth, Ratchawat Promraj, Nartsiri Ratchawang, A. Vongwiwatana, Peenida Skulratanasak
Publikováno v:
Transplantation Proceedings. 51:2629-2632
Background Mycophenolic acid (MPA) is one of the main immunosuppressive regimens used after kidney transplantation (KT). The less expensive, generic form of mycophenolate mofetil (MMF) (Immucept®) is recently available in Thailand. Comparisons of th
Autor:
Attapong Vongwiwatana, Panisara Klahan, Tippawan Sudrak, Nuttasith Larpparisuth, N. Premasathian
Publikováno v:
Transplantation. 104:S330-S330
Publikováno v:
Transplantation Proceedings. 46:469-473
Recipient glomerular filtration rate (GFR) after living kidney transplantation (KT) is influenced by many factors. Defining the appropriate level of recipient GFR post-KT is helpful. The aim of this study was to establish a predictive model to estima
Autor:
Phichaya Sujijantararat, Suchai Soontrapa, Teerapon Amornvesukit, Tawatchai Taweemonkongsap, Sittiporn Srinualnad, Anupan Tantiwong, N. Premasathian, Chaiyong Nualyong, Siros Jitpraphai
Publikováno v:
Transplantation Proceedings. 43:3593-3598
We report our experience with laparoscopic donor nephrectomy (LDN) compared with open donor nephrectomy (ODN). Prognostic factors associated with adverse outcomes in LDN were identified.From January 2000 to December 2009, 243 consecutive live-donor n
Autor:
Nuttasith Larpparisuth, A. Vongwiwatana, Kriengsak Vareesangthip, P. Parichatikanon, N. Premasathian, Boonyarit Cheunsuchon
Publikováno v:
Transplantation Proceedings. 46:474-476
Acute antibody-mediated rejection (AMR) is a major cause of early kidney allograft dysfunction. This study was conducted to examine the clinicopathologic features and long-term outcomes of early AMR in our center.We retrospectively reviewed all patie
Autor:
Vasant Sumethkul, N. Premasathian, Yingyos Avihingsanon, S. Jittiganont, Cholatip Pongskul, Atiporn Ingsathit
Publikováno v:
Transplantation Proceedings. 42:4017-4020
Kidney transplantation is the best treatment for end-stage renal disease patients. Delayed graft function (DGF) remains one of the major problems after cadaveric kidney transplantation. This study has reported the risk factors and outcomes of DGF usi